Abby Care Raises $82 Million in Series C Funding
Abby Care, a San Francisco-based company dedicated to empowering families to provide exceptional home care with clinical oversight and real-time documentation, has announced the successful closing of an $82 million Series C funding round. This round was led by Transformation Capital, with significant participation from CVS Health Ventures, Frist Cressey Ventures, Khosla Ventures, Pivotal Ventures, Sequoia Capital, and Thrive Capital.
Company Overview
Abby Care focuses on reducing hospitalizations by 46% through its innovative approach to home healthcare. By ensuring a 91% electronic visit verification (EVV) rate, the company supports families in delivering quality care at home. This commitment to effective and efficient home care solutions is spearheaded by Founder and CEO Havi Nguyen.
Strategic Investment
The Series C funding will enable Abby Care to further develop its technology platform and expand its services. Although specific use of funds was not detailed in the announcement, such investments typically support scaling operations, enhancing product offerings, and potentially expanding into new markets.
Lead Investor and Participants
Transformation Capital, known for investing in healthcare companies that leverage technology to improve patient outcomes, led the funding round. The participation of established investors like CVS Health Ventures and Sequoia Capital highlights the confidence in Abby Care's mission and growth potential.
Conclusion
With this substantial financial backing, Abby Care is well-positioned to enhance its service offerings and continue to impact the home healthcare sector positively. As more families seek effective home-based care solutions, Abby Care's role in this evolving landscape becomes increasingly crucial.